Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Specific Carbohydrate Diet
NORTHWEST BIOTHERAPEUTICS INC
Clostridium Difficile Infection
1 trial -
Split dose of 4L PEG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Health Behavior
1 trial -
Standard Dose Spirulina Platensis
Hospital Authority, Hong Kong
HBV Carrier
1 trial -
Standard OGTT
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
Standard of Care medication for early Alzheimer's Disease
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
Stapokibart
The First People's Hospital of Lianyungang
Primary Cutaneous Amyloidosis
1 trial -
Starch
Hong Kong Baptist University
Lens Opacity
1 trial -
Stereotactic body radiotherapy (SBRT)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HSCT
1 trial -
Steroid and Proton Pump Inhibitor Therapy
Takeda
Suspected Eosinophilic Esophagitis
1 trial -
Study Agent
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Study product A (Wonderlab wonder4shape)
Chongqing Precision Biotech Co., Ltd
Overweight and Obesity
1 trial -
Study product A (Wonderlab wonder4shape)
Chongqing Precision Biotech Co., Ltd
Overweight
1 trial -
Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval
Biotech Pharmaceutical Co.,
Diphtheria
1 trial -
Subconjunctival dexamethasone and general anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial -
Sucrose Iron，subcutaneous recombinant human erythropoietin，intravenous vitamin C
The First People's Hospital of Lianyungang
Anemia
1 trial -
Surgery combined with Target-reduction intensity-modulated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Symbiotic Formula with DHA and antioxidants
Quantum Biopharma
Cystic Fibrosis
1 trial -
Synbiotic
United Therapeutics Europe Ltd
Non-Alcoholic Fatty Liver Disease
1 trial -
Synovial Biopsy
Lakefront Biotherapeutics NV
Rheumatoid Arthritis
1 trial -
T, 260 mg/m2, paclitaxel for injection (albumin-bound)
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
TPO-RA
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Immune Thrombocytopenic Purpura
1 trial -
Tadalafil 2.5Mg Tab
Hospital Authority, Hong Kong
Erectile Dysfunction
1 trial -
Tafolecimab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Coronary Syndrome
1 trial -
Tamsulosin Hydrochloride
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Benign Prostatic Hyperplasia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources